BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 1479402)

  • 1. Prolactin secreting pituitary carcinoma.
    Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prolactin producing hypophyseal carcinoma. Case report of an extremely rare metastatic tumor].
    Saeger W; Bosse U; Pfingst E; Schierke G; Kulinna H; Atkins D; Gullotta F
    Pathologe; 1995 Sep; 16(5):354-8. PubMed ID: 7479609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
    Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature.
    Ozgen T; Oruckaptan HH; Ozcan OE; Acikgoz B
    Acta Neurochir (Wien); 1999; 141(12):1287-94. PubMed ID: 10672299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactinomas in men masquerading as invasive skull base tumours.
    Cook RJ; Uttley D; Wilkins PR; Archer DJ; Bell BA
    Br J Neurosurg; 1994; 8(1):51-5. PubMed ID: 8011194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
    Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant prolactinoma: where's the prolactin?
    Tailor C; Teo I; Sorisky A
    Clin Neurol Neurosurg; 2011 Nov; 113(9):810-2. PubMed ID: 21906866
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Bilbao I; Egaña N; García C; Olaizola I
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):564-566. PubMed ID: 29137963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
    Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
    No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
    Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
    Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
    Xiao Z; Yang X; Zhang K; Liu Z; Shao Z; Song C; Wang X; Li Z
    Int J Med Sci; 2020; 17(18):3174-3189. PubMed ID: 33173437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypophyseal prolactin-secreting macroadenomas].
    Candrina R; Tosoni M
    Recenti Prog Med; 1989 Sep; 80(9):471-3. PubMed ID: 2595078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
    Kupersmith MJ; Kleinberg D; Warren FA; Budzilovitch G; Cooper P
    Neurosurgery; 1989 Mar; 24(3):417-23. PubMed ID: 2927618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.
    Bevan JS; Adams CB; Burke CW; Morton KE; Molyneux AJ; Moore RA; Esiri MM
    Clin Endocrinol (Oxf); 1987 May; 26(5):541-56. PubMed ID: 3665118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis of an occult gastric carcinoma suggesting growth of a prolactinoma during bromocriptine therapy: a case report with a review of the literature.
    van Seters AP; Bots GT; van Dulken H; Luyendijk W; Vielvoye GJ
    Neurosurgery; 1985 Jun; 16(6):813-7. PubMed ID: 2989726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphological changes in prolactinoma induced by bromocriptine treatment].
    Scanarini M
    Minerva Endocrinol; 1990; 15(1):13-5. PubMed ID: 2274009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
    Kolodny J; Dluhy RG
    Am J Med; 1985 Jan; 78(1):153-5. PubMed ID: 3966480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spheroidal amyloid deposits in prolactin-secreting pituitary adenomas: report of a case].
    Yang YL; Liu B; Qian Z; Ha YD; Su QJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):776-7. PubMed ID: 20079021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.